BMA slams 1% pay increase for GPs

The British Medical Association has heavily criticised the Doctors and Dentists Review Body’s (DDRB) recommendations on doctor’s pay that has now been accepted by the government.
Ministers have confirmed a 1.16% overall rise in GP contract payments for 2015/16, saying this would deliver the 1% pay …

More details...

NICE medicines optimisation guidelines highlight data sharing deadline

Updated guidance from NICE on medicines optimisation notes that patients should be central to treatment decisions and that their data should ideally be sharable within 24 hours.
In publishing ‘Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes’ NICE is …

More details...

Bad diabetes care down to cost-cutting and lack of leadership

Healthcare professionals have said a combination of cost-cutting measures and a perceived lack of local and national leadership are leading to poor outcomes for diabetes patients.
This is according to findings from a new report A Diabetes Snapshot published by the ABPI Pharmaceutical Diabetes Initiative (PDI), …

More details...

NICE says people should share decision-making on medicines

In new guidance NICE is saying people should be more involved in decisions about the medicines they take to ensure they get the best outcomes from them.
Published today the medicines optimisation guideline declares that people should be placed at the centre of decisions about their …

More details...

BBC investigation reveals growing GP crisis

A survey on over 1000 UK doctors for the BBC’s Inside Out programme has found that more than half said they expect to leave the job or retire before they are 60.
The findings have also uncovered a national shortage of GPs, alongside junior doctors saying …

More details...

Private companies are pricing out GPs for out-of-hours services

A report by The Royal College of General Practitioners notes that doctors who want to run out-of-hours services face a ‘David versus Goliath’ tussle with large private companies.
The findings have given rise to calls for ministers to make the regulations for awarding contracts clearer, and …

More details...

NICE nods through two diabetic eye treatments

The National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending two new treatments for diabetic macular oedema.
The UK watchdog has shown the green light to aflibercept (Eylea, Bayer) as an option for the treatment of diabetic macular oedema (DMO) for people …

More details...

NICE lays down antimicrobial medicines guideline

NICE has set out its stall in proposing measures for health and social care providers to help tackle the increasing threat of antimicrobial resistance.
The UK health watchdog’s ultimate aim through the plans is to ensure that antibiotics continue to be successful in treating infections, as …

More details...

First biosimilar launches in Europe for inflammatory conditions

The first biosimilar monoclonal antibody for inflammatory conditions has been launched into major European markets.
Infliximab (Inflectra, Hospira) is a biosimilar – or copycat – biopharmaceutical drug that has the same active properties as the established Remicade brand (which is losing its patency) by co-owning pharma …

More details...

Doctors ‘outraged’ by NICE diabetes guidance

Exchanges between doctors captured via a study on social media have revealed that many have strong feelings towards new draft guidelines on the treatment of type 2 diabetes published by NICE.
Research conducted by Creation Healthcare looked at the responses by healthcare professionals to NICE draft …

More details...

Web design and marketing agency Leamington Spa